China National Medicines Corp., Ltd. operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares China National Medicines Corp., Ltd. with three other
drug stores in Asia:
sales of 2.19 billion Malaysian Ringgits [US$494.59 million]
of which 98%
was Logistics and Distribution),
Hokuyaku Takeyama Holdings, Inc
(225.15 billion Japanese Yen [US$2.02 billion]
of which 72%
was Pharmaceutical Business), and
Jiangsu Nhwa Pharmaceutical Company Limited
(3.02 billion Chinese Renmimbi [US$438.29 million]
of which 55%
was Medical Industrial Manufacturing).
During the year ended December of 2016, sales at
China National Medicines Corp., Ltd. were 13.39 billion Chinese Renmimbi (US$1.94 billion).
increase of 10.8%
versus 2015, when the company's sales were 12.08 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at China National Medicines Corp., Ltd.
(and since 2011, sales have increased a total of 90%).
Sales of Business Department saw an increase
11.3% in 2016, from
11.67 billion Chinese Renmimbi to 12.99 billion Chinese Renmimbi.
Not all segments of China National Medicines Corp., Ltd. experienced an increase in sales in 2016:
sales of Other fell 3.7% to 395.80 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).